Success Metrics

Clinical Success Rate

50.0%

Based on 1 completed trials

Completion Rate

50%(1/2)

Active Trials

1(25%)

Results Posted

100%(1 trials)

Terminated

1(25%)

Phase Distribution

Ph phase_3

25%

Ph phase_1

50%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution3 total trials

Phase 1Safety & dosage

2(66.7%)

Phase 3Large-scale testing

1(33.3%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

33.3%

1 of 3 finished

Non-Completion Rate

66.7%

2 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(1)

Completed(1)

Terminated(2)

Detailed Status

Completed1

Terminated1

Withdrawn1

Recruiting1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

50.0%

Most Advanced

Phase 3

Trials by Phase

Phase 12 (66.7%)

Phase 31 (33.3%)

Trials by Status

completed125%

terminated125%

withdrawn125%

recruiting125%

Recent Activity

1 active trials

Showing 4 of 4

recruitingphase_3

Safety and Efficacy of Botulinum Toxin A in Patients With Posttraumatic Headache

NCT06839118

withdrawnphase_1

Onabotulinum Toxin A (Botox) for the Treatment of Persistent Post-Stroke and Vascular Headache

NCT04580238

completed

Predictive Urodynamic Parameters for The Treatment Efficacy of Onabotulinum A Toxin in Neurogenic Lower Urinary Tract Dysfunction

NCT06485453

terminatedphase_1

Investigating Effects of BOTOX on Weight Loss and Glucose Tolerance in Obese, Type 2 Diabetic Subjects

NCT03991299

Clinical Trials (4)

Showing 4 of 4 trials

NCT06839118Phase 3

Safety and Efficacy of Botulinum Toxin A in Patients With Posttraumatic Headache

Recruiting

NCT04580238Phase 1

Onabotulinum Toxin A (Botox) for the Treatment of Persistent Post-Stroke and Vascular Headache

Withdrawn

NCT06485453

Predictive Urodynamic Parameters for The Treatment Efficacy of Onabotulinum A Toxin in Neurogenic Lower Urinary Tract Dysfunction

Completed

NCT03991299Phase 1

Investigating Effects of BOTOX on Weight Loss and Glucose Tolerance in Obese, Type 2 Diabetic Subjects

Terminated

All 4 trials loaded

Drug Details

Intervention Type: DRUG
Total Trials: 4